SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001209191-21-050473
Filing Date
2021-08-09
Accepted
2021-08-09 18:16:30
Documents
2
Period of Report
2021-08-09

Document Format Files

Seq Description Document Type Size
1 FORM 3 SUBMISSION doc3.html 3  
1 FORM 3 SUBMISSION doc3.xml 3 2174
2 EX-24 DOCUMENT attachment1.htm EX-24 3636
  Complete submission text file 0001209191-21-050473.txt   7215
Mailing Address 23515 NE NOVELTY HILL RD., SUITE B221 #1 REDMOND WA 98077
Business Address 23515 NE NOVELTY HILL RD., SUITE B221 #1 REDMOND WA 98077 16502240857
Eliem Therapeutics, Inc. (Issuer) CIK: 0001768446 (see all company filings)

IRS No.: 832273741 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O ELIEM THERAPEUTICS, INC. 23515 NE NOVELTY HILL RD, STE B221 #125 REDMOND WA 98053
Business Address
Levin Andrew David (Reporting) CIK: 0001867539 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-40708 | Film No.: 211157752